| Authors: |
Nepali PR; Department of Urology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA., Eraky A; Department of Urology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA., Okhawere KE; Department of Urology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA., Dogra N; Department of Genomic Sciences, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA.; Department of Pathology and Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA., Mehrazin R; Department of Urology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA., Badani K; Department of Urology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA., Kyprianou N; Department of Urology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA. Natasha.Kyprianou@mountsinai.org.; Department of Pathology and Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA. Natasha.Kyprianou@mountsinai.org.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA. Natasha.Kyprianou@mountsinai.org. |
